Welcome to the official website of BioCoreUSA Corp!
  • Cores:
    96
    CASES:
    64
    Core Diameter(mm):
    1
    Thickness(µm):
    5
    Row number:
    8
    Column number:
    12
    Tissue Array Type:
    FFPE
    Species:
    Human
BCN963a
$255.00
Add To Collect

Description: Multiple organ tumor array with matched or unmatched normal tissue, including pathology grade, TNM and clinical stage, 64 cases/96 cores, replacing BCN963

Details: Multiple organ tumor tissue microarray with matched or unmatched normal tissue, containing 16 types of organ cancer with matched or unmatched adjacent normal or cancer adjacent tissue (esophagus, stomach, colon, rectum, liver, lung, kidney, breast, cervix, ovary, bladder, lymph node, skin, cerebrum, prostate, pancreas), single or duplicate cores per case

Applications: Routine histology procedures including Immunohistochemistry (IHC) and In Situ Hybridization (ISH), protocols which can be found at our support page

Please Select Tissue Array Type:
Outright purchase
Note

1. TMA slides were sectioned and stored at 4°C and may not be fresh cut, but still suitable for IHC. Please request fresh cut if experiment involves phospho-specific antibodies, RNA studies, FISH or ISH, etc. A minimum of 3 slides per TMA must be purchased to cover the cost of trimming for fresh sectioning.
2. Most TMA slides were not coated with an extra layer of paraffin (tissue cores can be easily seen on the glass). To prevent tissue detachment during antigen retrieval, unbaked slides must be baked for at least 30 to 120 minutes at 60°C. before putting into xylene for de-paraffinization. Baked slides were sent out baked for 2 hours.
In the following specsheet,“*” means invalid core; “-” means no applicable or negative in IHC markers."

  • Specification sheet
  • Overlapping case
  • Download specifications
Legend:
Car-Cardia Eso-Fsophagus
  • NAT(*)
  • AT(*)
  • Malignant(*)
  • Malignant(IB1)
  • Normal(*)
  • Malignant(0)
  • Malignant(I)
  • Malignant(IA)
  • Malignant(IB)
  • Malignant(IIA)
  • Malignant(IIB)
  • Malignant(II)
  • Malignant(IIIA)
  • Malignant(IIIB)
  • Malignant(IIIC)
  • Malignant(III)
  • _ma
TISSUE ARRAYS
BCN963a
1
2
3
4
5
6
7
8
9
10
11
12
A
Eso
Eso
Eso
Sto
Sto
Sto
Col
Col
Col
Rec
Rec
Rec
B
Eso
Eso
Eso
Sto
Sto
Sto
Col
Col
Col
Rec
Rec
Rec
C
Liv
Liv
Liv
Lun
Lun
Lun
Kid
Kid
Kid
Bre
Bre
Bre
D
Liv
Liv
Liv
Lun
Lun
Lun
Kid
Kid
Kid
Bre
Bre
Bre
E
Cer
Cer
Cer
Ova
Ova
Ova
Bla
Bla
Bla
Lym
Lym
Lym
F
Cer
Cer
Cer
Ova
Ova
Ova
Bla
Bla
Bla
Lym
Lym
Lym
G
Ski
Ski
Ski
Cer
Cer
Cer
Pro
Pro
Pro
Pan
Pan
Pan
H
Ski
Ski
Ski
Cer
Cer
Cer
Pro
Pro
Pro
Pan
Pan
Pan
_ma
BCN963a
  • Age:
  • Sex:
  • Organ/Anatomic Site:
  • Pathology diagnosis:
  • Grade:
  • TNM:
  • Stage:
  • Tissue ID.:
  • Type:
Pos No. Age Sex Organ/Anatomic Site Pathology diagnosis Grade TNM Stage Type Tumor size
A1
1 52 M Esophagus Squamous cell carcinoma 1 T1N0M0 I Malignant 4.5*2*1
A2
2 58 F Esophagus Squamous cell carcinoma 1 T1bN0M0 I Malignant 2*2*0.8
A3
3 62 M Esophagus Squamous cell carcinoma 2 T2N0M0 II Malignant 4*3*1.5
A4
4 66 M Stomach Adenocarcinoma 3 T3N2M0 III Malignant *
A5
5 53 M Stomach Adenocarcinoma 3 T3N2M0 III Malignant *
A6
6 34 F Stomach Adenocarcinoma 3 T3N0M0 IIB Malignant *
A7
7 58 M Colon Papillary adenocarcinoma 1--2 T3N1bM0 IIIB Malignant 2.5*2.0*2.0
A8
8 37 M Colon Adenocarcinoma 2 T3N0M0 IIA Malignant 5.0*3.5*0.5
A9
9 63 F Colon Adenocarcinoma 3 T3N1M0 IIIB Malignant *
A10
10 43 M Rectum Tubular adenocarcinoma 1 T3N0M0 IIA Malignant 5.0*3.0*0.5
A11
11 51 M Rectum Adenocarcinoma 2 T4aN0M0 IIB Malignant *
A12
12 55 M Rectum Adenocarcinoma 3 T3N0M0 IIA Malignant 4.0*3.5*0.5
B1
13 52 M Esophagus Adjacent normal esophagus tissue of No.1 * * * NAT *
B2
14 58 F Esophagus Adjacent normal esophagus tissue of No.2 * * * NAT *
B3
15 62 M Esophagus Adjacent normal esophagus tissue of No.3 * * * NAT *
B4
16 66 M Stomach Adjacent normal stomach tissue of No.4 * * * NAT *
B5
17 53 M Stomach Cancer adjacent stomach tissue of No.5 * * * AT *
B6
18 34 F Stomach Adjacent normal stomach tissue of No.6 * * * NAT *
B7
19 58 M Colon Adjacent normal colon tissue of No.7 * * * NAT *
B8
20 37 M Colon Adjacent normal colon tissue of No.8 * * * NAT *
B9
21 63 F Colon Adjacent normal colon tissue of No.9 * * * NAT *
B10
22 43 M Rectum Adjacent normal rectum tissue of No.10 * * * NAT *
B11
23 51 M Rectum Adjacent normal rectum tissue of No.11 * * * NAT *
B12
24 55 M Rectum Adjacent normal rectum tissue of No.12 * * * NAT *
C1
25 48 F Liver Hepatocellular carcinoma 2 T3N0M0 IIIA Malignant 4*3*2
C2
26 52 F Liver Hepatocellular carcinoma 3 T2N0M0 II Malignant 6.0*4.5*4.5
C3
27 43 F Liver Hepatocellular carcinoma 3 T2N0M0 II Malignant 4*3*2
C4
28 67 M Lung Squamous cell carcinoma 2 T2N0M0 IB Malignant 4*3.5*3
C5
29 70 M Lung Squamous cell carcinoma 2 T3N0M0 IIB Malignant 5*4*4
C6
30 62 M Lung Squamous cell carcinoma 3 T2aN1M0 IIA Malignant 5*5*4
C7
31 72 F Kidney Clear cell carcinoma 1 T1bN0M0 I Malignant 5*3.5*3
C8
32 57 M Kidney Clear cell carcinoma 1 T1bN0M0 I Malignant 5.0*4.5*3.0
C9
33 45 F Kidney Clear cell carcinoma 1 T1N0M0 I Malignant 5*4*4
C10
34 53 F Breast Invasive carcinoma of no special type 2 T2N0M0 IIA Malignant *
C11
35 49 F Breast Invasive carcinoma of no special type 2 * * Malignant *
C12
36 29 F Breast Invasive carcinoma of no special type 3 T2N0M0 IIA Malignant *
D1
37 48 F Liver Cancer adjacent liver tissue of No.25 * * * AT *
D2
38 52 F Liver Adjacent normal liver tissue of N0.26 * * * NAT *
D3
39 43 F Liver Cancer adjacent liver tissue of No.27 * * * AT *
D4
40 67 M Lung Adjacent normal lung tissue of No.28 * * * NAT *
D5
41 70 M Lung Adjacent normal lung tissue of No.29 * * * NAT *
D6
42 62 M Lung Adjacent normal lung tissue of No.30 * * * NAT *
D7
43 72 F Kidney Adjacent normal kidney tissue of No.31 * * * NAT *
D8
44 57 M Kidney Adjacent normal kidney tissue of No.32 * * * NAT *
D9
45 45 F Kidney Cancer adjacent kidney tissue of No.33 * * * AT *
D10
46 53 F Breast Adjacent normal breast tissue of No.34 * * * NAT *
D11
47 49 F Breast Adjacent normal breast tissue of No.35 * * * NAT *
D12
48 29 F Breast Adjacent normal breast tissue of No.36 * * * NAT *
E1
49 71 F Cervix Squamous cell carcinoma 2 T1b1N0M0 IB1 Malignant 3.5*2.5*1.0
E2
50 58 F Cervix Squamous cell carcinoma 2 * * Malignant *
E3
51 42 F Cervix Squamous cell carcinoma 3 * * Malignant *
E4
52 58 F Ovary High grade serous carcinoma * T3cN0M0 IIIC Malignant *
E5
53 37 F Ovary High grade serous carcinoma * T1aN0M0 IA Malignant 6.5*4.5*3.0
E6
54 67 F Ovary High grade serous carcinoma * T1N0M0 I Malignant 13*12*6
E7
55 79 F Bladder Urothelial carcinoma * T2N0M0 II Malignant 10*5*1.5
E8
56 71 M Bladder Urothelial carcinoma * T3bN0M0 IIIA Malignant 8*7
E9
57 65 M Bladder Compound cancer * T4N0M0 IIIA Malignant 2.5*1.5*1
E10
58 39 M Lymph node Diffuse B-cell lymphoma of right armpit * * * Malignant *
E11
59 28 M Lymph node Diffuse B-cell lymphoma of left armpit * * * Malignant *
E12
60 51 M Lymph node Diffuse B-cell lymphoma of right thigh * * * Malignant 7*4*2
F1
61 45 F Cervix Adjacent normal cervix tissue * * * NAT *
F2
62 58 F Cervix Cancer adjacent cervix tissue of No.50 * * * AT *
F3
63 53 F Cervix Adjacent normal cervix tissue * * * NAT *
F4
64 64 F Ovary Adjacent normal ovary tissue * * * NAT *
F5
65 47 F Ovary Adjacent normal ovary tissue * * * NAT *
F6
66 29 F Ovary Adjacent normal ovary tissue * * * NAT *
F7
67 79 F Bladder Adjacent normal bladder tissue of No.55 * * * NAT *
F8
68 71 M Bladder Cancer adjacent bladder tissue of No.56 * * * AT *
F9
69 65 M Bladder Cancer adjacent bladder tissue of No.57 * * * AT *
F10
70 32 M Lymph node Lymph node tissue * * * Normal *
F11
71 35 M Lymph node Lymph node tissue * * * Normal *
F12
72 35 M Lymph node Lymph node tissue * * * Normal *
G1
73 69 M Skin Carcinoma in situ of right shin 2 T2N0M0 II Malignant 6.5*6*1.2
G2
74 78 M Skin Squamous cell carcinoma 2 T2N1M0 III Malignant *
G3
75 79 M Skin Squamous cell carcinoma of left thigh * TisN0M0 0 Malignant 3*2
G4
76 41 M Cerebrum Diffuse astrocytoma of left frontal lobe 2 * * Malignant 2*2*1
G5
77 38 M Cerebrum Diffuse astrocytoma of left frontal lobe 2 * * Malignant 3.5*2*1
G6
78 42 F Cerebrum Glioblastoma of right frontal lobe 4 * * Malignant 3*2*1
G7
79 56 M Prostate Adenocarcinoma (Gleason grade: 4; Gleason score:4+4) 3 T3N0M0 III Malignant 3*2.5
G8
80 64 M Prostate Adenocarcinoma (Gleason grade: 5; Gleason score: 5+5) 3 T2N0M0 II Malignant 8*7*5
G9
81 64 M Prostate Adenocarcinoma (Gleason grade: 5; Gleason score: 5+5) 3 T2bN0M0 II Malignant 7*6*4
G10
82 58 F Pancreas Adenocarcinoma 1 T3N1M0 IIB Malignant *
G11
83 55 M Pancreas Adenocarcinoma 2 T3N0M0 IIA Malignant *
G12
84 53 M Pancreas Dcut adenocarcinoma 2 T3N0M0 IIA Malignant *
H1
85 54 F Skin Skin tissue * * * Normal *
H2
86 78 M Skin Cancer adjacent skin tissue of No.74 * * * AT *
H3
87 79 M Skin Cancer adjacent skin tissue of No.75 * * * AT *
H4
88 41 M Cerebrum Cancer adjacent cerebrum tissue of No.76 * * * AT *
H5
89 38 M Cerebrum Cancer adjacent cerebrum tissue of No.77 * * * AT *
H6
90 61 F Cerebrum Cancer adjacent cerebrum tissue * * * AT *
H7
91 66 M Prostate Cancer adjacent prostate tissue * * * AT *
H8
92 71 M Prostate Cancer adjacent prostate tissue * * * AT *
H9
93 64 M Prostate Cancer adjacent prostate tissue * * * AT *
H10
94 42 M Pancreas Adjacent normal pancreas tissue * * * NAT *
H11
95 55 F Pancreas Adjacent normal pancreas tissue * * * NAT *
H12
96 51 M Pancreas Adjacent normal pancreas tissue * * * NAT *
_marker_
Find overlapping cases with this tissue array:
  • BCN963a
    File Format: .xlsx
    Release Date: 2025-01-17 15:27:50
    Download
0.934388s